MedPath

INtensity of OVarian stimualtion and Euploid Embryos (INOVEE Study)

Phase 1
Conditions
Infertility
MedDRA version: 20.1Level: LLTClassification code: 10016398Term: Female infertility Class: 10038604
Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
Registration Number
CTIS2023-507028-22-00
Lead Sponsor
Santiago Dexeus Font Fundacio Privada
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
110
Inclusion Criteria

Infertile patients with indication for IVF, Undergoing preimplantation genetic screening cycles, Age >= 38 and < 42 years old, AMH > 1.5 ng/ml and < 3.5 ng/ml (AMH result of up to one year will be valid), BMI 18.5 – 30 Kg/m2

Exclusion Criteria

Severe male factor requiring TESE (testicular sperm extraction), Administration of any other drug potentially interfering with the treatment, Contraindication for hormonal treatment, Recent history of severe disease requiring regular treatment (clinically significant concurrent medical condition that could compromise subject safety or interfered with the trial assessment)., Monogenic disease to be detected with PGT-M

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath